Abstract

Burkitt's lymphoma is a mature B-cell lymphoma that is characterized by a rapid proliferative rate and propensity for extranodal sites of involvement such as the gastrointestinal tract and central nervous system. This subtype of non-Hodgkin's lymphoma is associated with unique cytogenetic translocations involving the c-MYC oncogene on chromosome 8, which appears to be involved in the pathogenesis of this disease. Although current literature is limited by a lack of randomized trials, Burkitt's lymphoma appears to be curable in a high proportion of cases if treated with aggressive multiagent chemotherapy regimens. The use of autologous stem cell transplantation appears to benefit patients who have had chemotherapy-sensitive relapses. The role of allogeneic stem cell transplantation for this disease remains uncertain. Patients with HIV-associated Burkitt's lymphoma appear to have a better prognosis today, which is likely a result of more effective antiretroviral therapy and the ability to treat selected patients with more aggressive chemotherapeutic regimens than before. This article will review the epidemiologic, biologic, diagnostic, and therapeutic aspects of Burkitt's lymphoma in adults.

Original languageEnglish (US)
Pages (from-to)11-20
Number of pages10
JournalClinical lymphoma
Volume6
Issue number1
DOIs
StatePublished - Jun 2005

Keywords

  • B cells
  • Central nervous system
  • Epstein-Barr virus
  • HIV
  • Stem cell transplantation

ASJC Scopus subject areas

  • Cancer Research

Fingerprint Dive into the research topics of 'Adult Burkitt's lymphoma'. Together they form a unique fingerprint.

  • Cite this